Neo Ivy Capital Management’s HCA Healthcare HCA Stock Holding History

Neo Ivy Capital Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,456	Closed	-$503K	–	409
2025 Q1	$503K	Buy	1,456 +253	+21%	+$81.4K	0.16%	196
2024 Q4	$361K	Buy	+1,203	New	+$420K	0.07%	182
2024 Q3	–	Sell	-940	Closed	-$302K	–	321
2024 Q2	$302K	Buy	+940	New	+$305K	0.06%	190
2022 Q3	–	Sell	-1,915	Closed	-$321K	–	447
2022 Q2	$321K	Sell	1,915 -215	-10%	-$46.2K	0.86%	18
2022 Q1	$534K	Buy	2,130 +1,438	+208%	+$361K	0.48%	62
2021 Q4	$178K	Sell	692 -684	-50%	-$167K	0.26%	150
2021 Q3	$134K	Buy	+1,376	New	+$336K	0.15%	205
2020 Q3	–	Sell	-1,376	Closed	-$134K	–	526
2020 Q2	$134K	Sell	1,376 -917	-40%	-$95.3K	0.15%	205
2020 Q1	$206K	Buy	+2,293	New	+$297K	0.34%	110
2019 Q4	–	Sell	-711	Closed	-$85K	–	317
2019 Q3	$85K	Buy	+711	New	+$91.9K	0.06%	236
2019 Q2	–	Sell	-4,030	Closed	-$525K	–	331
2019 Q1	$525K	Buy	+4,030	New	+$541K	0.3%	149

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Neo Ivy Capital Management's HCA Position: Q2 2025 in Review

Neo Ivy Capital Management sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 1,456 shares — an estimated $503K sold.

Neo Ivy Capital Management first reported a position in HCA in Q1 2019 and held it in 11 quarters. The position peaked at $534K in Q1 2022. 1,249 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

Neo Ivy Capital Management reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 1,456 HCA Healthcare shares in Q2 2025, an estimated $503K.
Neo Ivy Capital Management first reported a position in HCA Healthcare in Q1 2019 and held it in 11 quarters.
Neo Ivy Capital Management's HCA Healthcare position peaked at $534K in Q1 2022.
1,249 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Neo Ivy Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.